Improving the lives of patients with
metabolic obstructive sleep apnea (MOSA)
 A Transformative Approach
11
Apr

Mosanna Therapeutics Announces a Seed Extension Financing Round to Complete Preparations to Enter the Clinic with MOS-118 in Metabolic Obstructive Sleep Apnea

Company pursuing a highly differentiated small molecule MOS-118 in Metabolic Obstructive Sleep Apnea. New investors,...
Read More